Clinical Trials Browser

Neoplasm Metastasis, Colorectal Neoplasms

Anus Neoplasms, Rectal Neoplasms, HIV Infections

Colorectal Neoplasms

Stomach Neoplasms

Adenocarcinoma Of Esophagus, Breast Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms

Rectal Neoplasms

Pancreatic Ductal Adenocarcinoma

Colonic Neoplasms

Stomach Neoplasms

HER2-positive Gastric Cancer

Pathologic Complete Response, Rectal Neoplasms

Rectal Neoplasms

Locally Advanced Rectal Cancer With Liver Metastases

Stomach Neoplasms

Adenocarcinoma Of Esophagus, Neoplasm Metastasis, Stomach Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

Adenocarcinoma, Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma

Locally Advanced Rectal Cancer

Bile Duct Neoplasms, Biliary Tract Neoplasms

Anus Neoplasms

Rectal Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Locally Advanced Rectal Cancer

Rectal Neoplasms

Stomach Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Advanced Colorectal Cancer

Colorectal Cancer Metastatic

Biliary Tract Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Colonic Neoplasms

Appendiceal Neoplasms, Neoplasm Metastasis

Stomach Neoplasms

Pancreatic Neoplasms

Breast Neoplasms, Head and Neck Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Cervical Esophagus Adenocarcinoma

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Colonic Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Biliary Tract Neoplasms

Anus Neoplasms

Locally Advanced Rectal Cancer

Clinical Trials

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

MK-3475-06C

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

TRIUNITE-08

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

DG-03

Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer

SMART TNT

A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)

Adaptive Radiation in Anal Cancer

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

LAP100

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

TORCH-iTNT

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

NEO-RT

WW3

mRCAT-E

Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma

Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

NeoCHIC

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study

MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer

KANALRAD

Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)